Top compounds associated with response to MT1B


Feature Type Standardized
Nominal ANOVA
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.025 0.5
mRNA itraconazole CTRPv2 pan-cancer AAC -0.025 0.5
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA ATRA CTRPv2 pan-cancer AAC -0.023 0.5
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.023 0.5
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.023 0.5
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.033 0.5
mRNA PF-184 CTRPv2 pan-cancer AAC 0.021 0.5
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.5
mRNA BEC CTRPv2 pan-cancer AAC 0.047 0.5
Download CSV